| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/11/2005 | US6841384 Advanced roller bottle system for cell and tissue culturing |
| 01/11/2005 | US6841383 Insertion of preferential nucleotide seqences into genome; ontain nucleotide sequences, incubate with cells, transform recover cell expressing preferential marker |
| 01/11/2005 | US6841382 Nucleotide sequences coding protein for use in treatment of cancer, inflammation, arthritis and psoriasis |
| 01/11/2005 | US6841380 Apparatus for providing an environment of controlled water activity for storage of nematodes |
| 01/11/2005 | US6841373 Preparing replication defective viral vector for gene transfer tool; genetic engineering |
| 01/11/2005 | US6841371 Comprises anticoagulant polypeptide for treatment and prevention of acute coronary syndromes, vascular occlusive disorders and thrombosis |
| 01/11/2005 | US6841367 Human receptor tyrosine kinase, KDR |
| 01/11/2005 | US6841356 Cultivating tissues and monitoring interaction with modulator agents; drug discovery and screening; tissue engineering |
| 01/11/2005 | US6841353 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of HCV viral antigen in host tissue |
| 01/11/2005 | US6841157 Wherein early genes are from a first type of papillomavirus and the late genes are from a second papillomavirus |
| 01/11/2005 | US6841151 Chondrocyte cells for use in the treatment of arthritic and bone disorders |
| 01/11/2005 | US6841150 Incubating with chondroinductive agent that activates cellular transduction leading to mature phenotype, antibiotic, fetal bovine serum or horse serum, vitamin C, and glucocorticoid |
| 01/11/2005 | CA2342072C Kunitz domain polypeptide zkun6 |
| 01/11/2005 | CA2337099C Enzymes for biopolymer production |
| 01/11/2005 | CA2337088C Methods and constructs for protein expression |
| 01/11/2005 | CA2267670C Method for preparing human stem cell factor polypeptide |
| 01/11/2005 | CA2169631C A novel homeobox factor which stimulates insulin expression in pancreatic islet cells |
| 01/09/2005 | CA2469137A1 Neutral protease (np) and product by using neutral protease for tissue dissociation as well as method for the production thereof |
| 01/06/2005 | WO2005001732A1 Medical care self-cell delivery support system, medical care self-cell delivery support financial system, and their methods |
| 01/06/2005 | WO2005001110A2 Transcriptional regulation of gene expression by small double-stranded modulatory rna |
| 01/06/2005 | WO2005001103A2 Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses |
| 01/06/2005 | WO2005001102A1 Plant virus vector |
| 01/06/2005 | WO2005001087A2 Methods of modifying genes in eukaryotic cells |
| 01/06/2005 | WO2005001081A1 Method of isolating cells from umbilical cord |
| 01/06/2005 | WO2005001080A2 Postpartum-derived cells for use in treatment of disease of the heart and circulatory system |
| 01/06/2005 | WO2005001079A2 Soft tissue repair and regeneration using postpartum-derived cells |
| 01/06/2005 | WO2005001078A2 Regeneration and repair of neural tissue using postpartum-derived cells |
| 01/06/2005 | WO2005001077A2 Repair and regeneration of ocular tissue using postpartum-derived cells |
| 01/06/2005 | WO2005001076A2 Postpartum cells derived from placental tissue, and methods of making and using the same |
| 01/06/2005 | WO2005001075A1 Rdp58 compositions and methods for modulating the activity of osteoclasts and osteoblasts |
| 01/06/2005 | WO2005001074A1 Allogeneic cell therapy: mirror effect |
| 01/06/2005 | WO2005001073A1 Method for differentiating stem cells in cells that produce a pancreatic hormone |
| 01/06/2005 | WO2005001072A1 Isolated pluripotent adult stem cells and methods for isolating and cultivating the same |
| 01/06/2005 | WO2005001070A1 Magnetic cell and method of using the same |
| 01/06/2005 | WO2005001054A2 Methods of producing neurons |
| 01/06/2005 | WO2005001042A2 Smooth muscle progenitor cells |
| 01/06/2005 | WO2005001033A2 Tolerance induction and maintenance in hematopoietic stem cell allografts |
| 01/06/2005 | WO2005001026A2 Adks as modifiers of the pten pathway and methods of use |
| 01/06/2005 | WO2005001025A2 Immunoglobulin chimeric monomer-dimer hybrids |
| 01/06/2005 | WO2005001019A1 Container for germ layer formation and method of forming germ layer |
| 01/06/2005 | WO2005000901A2 Cd20-specific antibodies and methods of employing same |
| 01/06/2005 | WO2005000890A1 Method for transplanting lymphohematopoietic cells into mammal |
| 01/06/2005 | WO2005000888A2 NOVEL β-ACTIN AND RPS21 PROMOTERS AND USES THEREOF |
| 01/06/2005 | WO2005000870A2 Isolated ny-eso-1 peptides which bind to hla class ii molecules and uses thereof |
| 01/06/2005 | WO2005000376A2 Bio-artificial liver system |
| 01/06/2005 | WO2005000344A2 Method for identification of tr1 lymphocytes regulators by the presence and overexpression of specific molecules and application thereof |
| 01/06/2005 | WO2005000342A1 Peptides derived from the protein mmp-2, and the use thereof in antitumoral immunotherapy |
| 01/06/2005 | WO2005000198A2 An intracellular estradiol binding protein, a polynucleotide encoding the same and cell lines overexpressing the same |
| 01/06/2005 | WO2005000032A1 Method for treatment of sores and lesions of the skin |
| 01/06/2005 | WO2004098285A3 Cryopreservation of human blastocyst-derived stem cells by use of a closed straw vitrification method |
| 01/06/2005 | WO2004087756A3 Antibodies against insulin-like growth factor i receptor and uses thereof |
| 01/06/2005 | WO2004080175B1 Scaffold for cell growth and differentiation |
| 01/06/2005 | WO2004072117A3 Antibodies to c-met for the treatment of cancers |
| 01/06/2005 | WO2003050255A3 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer |
| 01/06/2005 | WO2003020890A3 Genes encoding baeyer-villiger monooxygenases |
| 01/06/2005 | WO2002096923A9 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes |
| 01/06/2005 | WO2002055700A8 Human genes and gene expression products isolated from human prostate |
| 01/06/2005 | US20050005335 Selecting for a mutation by incubating seeds in a solution comprising a mutagen, washing and germinating; chimeric plants with high amino acid content; useful for improving flavor and aroma |
| 01/06/2005 | US20050005329 Isolated nucleotide sequence encoding polypeptide derived from algae Isochrysis galbana; expression of vector results in production of polyunsaturated fatty acid; use in pharmaceutical compositions, animal feeds and cosmetics |
| 01/06/2005 | US20050005328 Nucleotide sequence encoding a polypeptide derived from fungus Thraustochytrium aureum; expression of vector results in production of polyunsaturated fatty acid (omega 6-docosapentaenoic acid and docosahexaenoic acid); use in pharmaceutical compositions, animal feeds and cosmetics |
| 01/06/2005 | US20050005323 Using expression vector comprising nucleotide sequences coding sucrose isomerase as tool in generating transgenic plants with increased carbohydrate concentration; for use in fermenting compounds such as methanol, ethanol and 1,3 propandiol |
| 01/06/2005 | US20050005318 Using micromanipulation and microtubule inhibitors to enucleate oocytes; generating cloned animal embryos for use in treatment and prevention nervous sytem disorders and heart disease; in vitro fertilization |
| 01/06/2005 | US20050005316 Extracellular matrix signaling molecules |
| 01/06/2005 | US20050005312 Propagation of human hepatocytes in non-human animals |
| 01/06/2005 | US20050004355 Diagnosing immune system disorders using defensin specific immuoglobulin; microbiocides and treatment of respiratory system disorders |
| 01/06/2005 | US20050004352 Single-chain multiple antigen-binding molecule, its preparation and use |
| 01/06/2005 | US20050004351 Therapeutic and diagnostic domain 1 beta2GP1 polypeptides and methods of using same |
| 01/06/2005 | US20050004346 Recombinant anti-plasmodium falciparum antibodies |
| 01/06/2005 | US20050004072 Methods and compositions for poly-beta-1-4-N-acetylglucosamine cell therapy system |
| 01/06/2005 | US20050004056 Ptp10d, tec protein tyrosine kinase and edtp homologous proteins involved in the regulation of energy homeostasis |
| 01/06/2005 | US20050004055 Synergistic process; electrical stimulation; administering hyaluronidase |
| 01/06/2005 | US20050004037 Osteogenic growth oligopeptides as stimulants of hematopoiesis |
| 01/06/2005 | US20050004034 Human C-Maf compositions and methods of use therefor |
| 01/06/2005 | US20050004028 modulating cell growth, cell differentiation, or cell survival; genetic engineering using hedgehog genes and proteins; neurodegenerative diseases; tissue-targeted therapy |
| 01/06/2005 | US20050004021 Enzyme inhibitor for therapy of thrombosis, blood disorders |
| 01/06/2005 | US20050004015 Novel haemopoietin receptor and genetic sequences encoding same |
| 01/06/2005 | US20050003998 Therapeutic use of selective LXR modulators |
| 01/06/2005 | US20050003985 From Bacillus; hybrid protein; detergents, cleaning compounds |
| 01/06/2005 | US20050003546 Viral uptake into cells and tissues |
| 01/06/2005 | US20050003545 Transgenic cells comprising plasmid for use as tool in heterologous gene delivery and cancer treatment |
| 01/06/2005 | US20050003544 Enriched or purified population of motor neurons and its preparation from a population of embryonic stem cells |
| 01/06/2005 | US20050003543 Methods of modifying genes in eukaryotic cells |
| 01/06/2005 | US20050003541 Transgenic embryonic stem cells comprising vector coding RNA interfering sequences for use in generating gene knockout animal models; gene expression analysis |
| 01/06/2005 | US20050003538 Double-transfected cell line useful for the identification of transport inhibitors |
| 01/06/2005 | US20050003535 Bioreactor for cell self-assembly in form of an organ copy; procedures for the production and the application of cell culture, differentiation, maintenance, proliferation and/or use of cells |
| 01/06/2005 | US20050003534 Human stem cell materials and methods |
| 01/06/2005 | US20050003533 Antigen presenting cells with enhanced interleukin expression for use in treatment and prevention of infection, cancer, inflammation, allergies and autoimmune disorders |
| 01/06/2005 | US20050003532 Ectocornea-like sheet and method of constructing the same |
| 01/06/2005 | US20050003531 Isolating and generating postmitotic neurons from embryonic spinal cord tissue that are capable of multiple neuronal phenotypes for use in treatment and prevention of nervous system disorders |
| 01/06/2005 | US20050003530 Bioreactor for neuronal cells and hybrid neuronal cell systems |
| 01/06/2005 | US20050003529 Stem cells and method of separating the same |
| 01/06/2005 | US20050003528 Methods for isolation of osteoclast precursor cells and inducing their differentiation into osteoclasts |
| 01/06/2005 | US20050003527 Preparing prostate subpopulations via inoculating nutrient broth comprising collagen support matrix, estrogen and dihydrotestosterone with stromal tissues; for use as model systems for screening antiproliferative agents |
| 01/06/2005 | US20050003526 Preparing porcine stem cell cultures via inoculating nutrient broth comprising stem cell factor and interleukins with bone marrow and/or fetal liver stem cells; for use in identifying therapeutiic agents for treatment of allergenic and hypersensitivity disorders |
| 01/06/2005 | US20050003512 Attenuated pasteurella for use as tool in developing bactericidal agents; immunotherapy |
| 01/06/2005 | US20050003506 Viral packaging cells for use as gene transfer and expression tools in genetic engineering; bioreactor |
| 01/06/2005 | US20050003504 Alkaline protease from Bacillus gibsonii (DSM 14391) and washing and cleaning products comprising said alkaline protease |
| 01/06/2005 | US20050003500 Producing optically active vicinal diols via reacting (2S,3S)-2,3-butanediol dehydrogenase, microorganism, 2,3-butanedione and (2S,3S)-2,3-butanediol in presence of reduced nicotinamide adenine dinucleotides; for use as raw material in flavors and pharmeceuticals |
| 01/06/2005 | US20050003492 Novel polypeptide |
| 01/06/2005 | US20050003490 Immunoglobulins specific for cell surface protein for use in diagnosis, prevention and treatment of cell proliferative disorders; inhibitory action associated with reduced cellular transport of amino acids |